---
title: Cook Iliac Branch Graft Post-market Registry
nct_id: NCT01055275
overall_status: TERMINATED
sponsor: Cook Group Incorporated
study_type: OBSERVATIONAL
primary_condition: Iliac Aneurysm
countries: Spain
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01055275.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01055275"
ct_last_update_post_date: 2013-06-20
last_seen_at: "2026-05-12T07:14:32.785Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Cook Iliac Branch Graft Post-market Registry

**NCT ID:** [NCT01055275](https://clinicaltrials.gov/study/NCT01055275)

## Key Facts

- **Status:** TERMINATED
- **Why Stopped:** Terminated due to low enrollment.
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 2
- **Lead Sponsor:** Cook Group Incorporated
- **Conditions:** Iliac Aneurysm, Aortic Aneurysm
- **Start Date:** 2010-09
- **Completion Date:** 2012-08
- **CT.gov Last Update:** 2013-06-20

## Brief Summary

The Cook Iliac Branch Graft Post-market Registry will obtain case reports of physician experience with a CE-marked Cook Iliac Branch Graft to further confirm device safety and performance.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* CE-Marked Cook Iliac Branch Graft (e.g., Zenith® Branch Endovascular Graft-Iliac Bifurcation, Zenith® Helical Branch Endovascular Graft)
* Registry data are de-identified with respect to patient.

Exclusion Criteria:

* Patient for whom this device would not normally be considered standard of care.
```

## Arms

- **Cook Iliac Branch Graft** — Patients implanted with a Cook Iliac Branch Graft

## Interventions

- **Implantation with a Cook Iliac Branch Graft** (DEVICE) — Treatment of an aortic, aorto-iliac or iliac aneurysm with a CE-marked Cook Iliac Branch Graft.

## Primary Outcomes

- **Internal iliac artery patency** _(time frame: 1 year)_
- **Aneurysm Exclusion** _(time frame: 1 year)_

## Secondary Outcomes

- **Death** _(time frame: 1 year)_
- **Conversion** _(time frame: 1 year)_
- **Rupture** _(time frame: 1 year)_
- **Success Measures** _(time frame: 1 year)_
- **Major Complications** _(time frame: 1 year)_

## Locations (1)

- Hospital Clinic, Barcelona, Spain

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.hospital clinic|barcelona||spain` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01055275.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01055275*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*